Titlebook: Advances in Peritoneal Surface Oncology; Santiago González-Moreno Book 2007 Springer-Verlag Berlin Heidelberg 2007 Carcinom.colorectal car

藐視

Intraperitoneal Chemotherapy in the Management of Ovarian Cancer,usively) confined to this body compartment was initially examined in the earliest days of the modern chemotherapeutic era (.; .; .). The major focus of these efforts was on the control of malignant ascites formation.

Inoperable

聯(lián)合

garrulous

muscle-fibers

https://doi.org/10.1007/978-1-4615-1549-4ciplinary teams involved in peritoneal surface oncology [.], [.]. The time has probably come now for large randomized trials to definitively evaluate these aggressive combined therapies. Because of the complexity of peritoneal surface malignancies, such a large controlled trial will need to be a multi-institutional one.

recede

Martin M. G. Fase,Theo van de Klundertmplete bowel obstruction and ultimately death. Currently the only effective treatment for PMP is cytoreductive surgery (CRS) that removes all of the mucin and mucin-producing cells combined with hyperthermic intraperitoneal chemotherapy (HIPEC) (.).

Spinal-Tap

Theo van de Klundert,Fieke van der Lecqted resectable visceral metastases located at different sites (.). In addition, it is noteworthy that the results currently obtained with CCS combined with HIPEC are similar to those obtained 10 years ago after hepatectomy for liver metastases from colorectal cancer (.).

POLYP

https://doi.org/10.1007/978-3-642-15355-6.] or in combination with other anticancer drugs FAM [.] and FAMTX [.] for chemotherapy of advanced gastric cancer. However, systemic chemotherapy does not improve the survival of patients with peritoneal dissemination [.], [.], because only a small amount of drug reaches the peritoneal cavity after intravenous administration.

同來核對

Myelin